Target Price | $29.38 |
Price | $24.80 |
Potential |
18.49%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Nurix Therapeutics Inc 2025 .
The average Nurix Therapeutics Inc target price is $29.38.
This is
18.49%
register free of charge
$36.00
45.16%
register free of charge
$15.00
39.52%
register free of charge
|
|
A rating was issued by 13 analysts: 12 Analysts recommend Nurix Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nurix Therapeutics Inc stock has an average upside potential 2025 of
18.49%
register free of charge
|
Nov '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 76.99 | 58.90 |
99.30% | 23.50% | |
EBITDA Margin | -183.67% | -296.09% |
59.00% | 61.20% | |
Net Margin | -221.53% | -323.46% |
64.16% | 46.01% |
11 Analysts have issued a sales forecast Nurix Therapeutics Inc 2024 . The average Nurix Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Nurix Therapeutics Inc EBITDA forecast 2024. The average Nurix Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Nurix Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Nurix Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Nov '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.65 | -2.96 |
28.57% | 11.70% | |
P/E | negative | |
EV/Sales | 20.09 |
5 Analysts have issued a Nurix Therapeutics Inc forecast for earnings per share. The average Nurix Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Nurix Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Nurix Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.